Skip to content
AHF Americas Health Foundation 501 (c)(3) non-profit foundation
  • Date

  • Year

  • WHO WE ARE
  • SERVICE LINES
    • ► CONSENSUS CONFERENCES
    • ► WORKSHOPS
    • ► TASK FORCES
    • ► AWARENESS PROJECTS
    • ► POLICY FORUMS AND WEBINARS
    • ► LANDSCAPE ANALYSIS
    • ► CONGRESS ON RARE DISEASES
  • TOPICS
    • ► ONCOLOGY
    • ► DIAGNOSTICS
    • ► RARE DISEASES
    • ► INFECTIOUS DISEASES
    • ► INFLAMMATORY DISEASES
    • ► CARDIOMETABOLIC DISEASES
    • ► WOMEN’S HEALTH
    • ► BIOSIMILARS
    • ► NEUROLOGY
    • ► OTHERS
  • WHO WE WORK WITH
    • ► CORPORATE SPONSORS
    • ► ORGANIZATION PARTNERS
    • ► EXPERTS & KOLS
  • WORLDWIDE
  • CONTACT US
  • NEWSROOM
  • DONATE
Menu Close
  • WHO WE ARE
  • SERVICE LINES
    • ► CONSENSUS CONFERENCES
    • ► WORKSHOPS
    • ► TASK FORCES
    • ► AWARENESS PROJECTS
    • ► POLICY FORUMS AND WEBINARS
    • ► LANDSCAPE ANALYSIS
    • ► CONGRESS ON RARE DISEASES
  • TOPICS
    • ► ONCOLOGY
    • ► DIAGNOSTICS
    • ► RARE DISEASES
    • ► INFECTIOUS DISEASES
    • ► INFLAMMATORY DISEASES
    • ► CARDIOMETABOLIC DISEASES
    • ► WOMEN’S HEALTH
    • ► BIOSIMILARS
    • ► NEUROLOGY
    • ► OTHERS
  • WHO WE WORK WITH
    • ► CORPORATE SPONSORS
    • ► ORGANIZATION PARTNERS
    • ► EXPERTS & KOLS
  • WORLDWIDE
  • CONTACT US
  • NEWSROOM
  • DONATE

Dr. Gilberto Castañeda, Mexico

Dr. Gilberto Castañeda Pharmacology Mexico Dr. Castañeda-Hernández is currently the Senior Investigator at the Departmento de Farmacología (Department of Pharmacology), Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional…

Continue ReadingDr. Gilberto Castañeda, Mexico
  • Post published:April 26, 2024
  • Post category:C-57 Biosimilar Interchangeability in LATAM/E&K-Biosimilars

Dr. Bianca Loyo Pona Schiavetti, Brazil

Dr. Bianca Loyo Pona Schiavetti Gastroenterology Brazil Gastroenterologist with special expertise in Inflammatory Bowel Diseases.

Continue ReadingDr. Bianca Loyo Pona Schiavetti, Brazil
  • Post published:April 26, 2024
  • Post category:C-57 Biosimilar Interchangeability in LATAM/E&K-Biosimilars

Enrique Teran, Ecuador

Dr. Enrique Teran Pharmacologist and President of the Academy of Sciences of Ecuador Ecuador  

Continue ReadingEnrique Teran, Ecuador
  • Post published:May 21, 2023
  • Post category:C-57 Biosimilar Interchangeability in LATAM/E&K- Rare Diseases/E&K-Biosimilars/Landing RD Congress

Manuel Espinoza, Chile

Dr. Manuel Espinoza Head of the Health Technology Assessment Unit of the Clinical Research Center, Pontificia Universidad Católica de Chile Chile  

Continue ReadingManuel Espinoza, Chile
  • Post published:May 21, 2023
  • Post category:C-57 Biosimilar Interchangeability in LATAM/E&K- Rare Diseases/E&K-Biosimilars/Landing RD Congress

Luis Pino, Colombia

Dr. Luis Pino Medical Oncologist. Founder and CEO of OxLER Colombia  

Continue ReadingLuis Pino, Colombia
  • Post published:May 19, 2023
  • Post category:C-57 Biosimilar Interchangeability in LATAM/E&K- Rare Diseases/E&K-Biosimilars/Landing RD Congress

Eva Maria Ruiz de Castilla, Peru

Eva Maria Ruiz de Castilla Managing Partner Peru Global leader in patient-based organizational capacity building and alliance development covering several therapeutic areas, including cancer, NCDs and rare diseases. She is…

Continue ReadingEva Maria Ruiz de Castilla, Peru
  • Post published:December 18, 2019
  • Post category:C4-Biosimilars/E&K-Biosimilars

Dr. Eduardo Mysler, Argentina

Dr. Eduardo Mysler Internal Medicine Argentina Graduated summa cum laude from the School of Medicine, University of Buenos Aires, Argentina. He went on to do an Internal Medicine residency in…

Continue ReadingDr. Eduardo Mysler, Argentina
  • Post published:December 18, 2019
  • Post category:C4-Biosimilars/E&K-Biosimilars

Dr. Marcelo Mario Mato Moreira, Brazil

Dr. Marcelo Mario Mato Moreira Coordinator Brazil Coordinator – Office of Biological Products Office of Biological Products The Brazilian Health Surveillance Agency (ANVISA).  

Continue ReadingDr. Marcelo Mario Mato Moreira, Brazil
  • Post published:December 18, 2019
  • Post category:C5- Safety & Effectiveness of Biosimilars/E&K-Biosimilars

Dr. Jose Julian Lopez, Colombia

Dr. Jose Julian Lopez Director Colombia Director of the Center for Medicines of the National University of Colombia.

Continue ReadingDr. Jose Julian Lopez, Colombia
  • Post published:December 18, 2019
  • Post category:C5- Safety & Effectiveness of Biosimilars/E&K-Biosimilars

Dr. Pedro Lipszyc, Argentina

  Dr. Pedro Lipszyc Professor and Director Argentina Full Professor and Director of the Department of Pharmacology Faculty of Medicine of the University of Buenos Aires (Argentina).

Continue ReadingDr. Pedro Lipszyc, Argentina
  • Post published:December 18, 2019
  • Post category:C5- Safety & Effectiveness of Biosimilars/E&K-Biosimilars
Older Posts →

AHF Americas Health Foundation 501 (c)(3) non-profit foundation is proudly powered by WordPress